Inj, tebentafusp-tebn, 1 mcg
Products billed under this code include Kimmtrak.
Payment limit per 1 MCG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Kimmtrak.
Payment limit per 1 MCG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Kimmtrak | Immunocore Commercial LLC | 80446-0401-01 | 100 | $22,800.60 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $228.006 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted September 17, 2026 |
| 3Q26 | $228.006 | +$5.512 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted September 15, 2026 |
| 2Q26 | $222.494 | +$0.284 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted September 15, 2026 |
| 1Q26 | $222.21 | +$5.122 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted September 15, 2026 |
| 4Q25 | $217.088 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted September 8, 2026 |
| 3Q25 | $217.088 | +$2.332 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted March 10, 2026 |
| 2Q25 | $214.756 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted March 10, 2026 |
| 1Q25 | $214.756 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted December 19, 2025 |
| 4Q24 | $214.756 | +$0.196 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted June 11, 2025 |
| 3Q24 | $214.56 | +$5.634 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted June 11, 2025 |
| 2Q24 | $208.926 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted March 11, 2025 |
| 1Q24 | $208.926 | +$5.099 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted December 19, 2024 |
| 4Q23 | $203.827 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted October 10, 2024 |
| 3Q23 | $203.827 | +$4.971 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted June 5, 2024 |
| 2Q23 | $198.856 | $0.00 | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted February 23, 2024 |
| 1Q23 | $198.856 | – | 1 MCG | Inj, tebentafusp-tebn, 1 mcg | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.